A Zander

1.4k total citations
51 papers, 1.1k citations indexed

About

A Zander is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, A Zander has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 15 papers in Oncology and 11 papers in Immunology. Recurrent topics in A Zander's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (9 papers) and Virus-based gene therapy research (7 papers). A Zander is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (9 papers) and Virus-based gene therapy research (7 papers). A Zander collaborates with scholars based in Germany, United States and Spain. A Zander's co-authors include H.T. Hassan, William Krüger, M Stockschläder, Nicolaus Kröger, R. Jung, Kay Uwe Petersen, Christoph Wagener, Monika Wolf, Michael Neumaier and Francis Ayuk and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

A Zander

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Zander Germany 17 465 420 317 273 131 51 1.1k
A.D. Donnenberg United States 16 353 0.8× 264 0.6× 204 0.6× 618 2.3× 69 0.5× 38 1.2k
Claude Baillou France 20 442 1.0× 243 0.6× 449 1.4× 467 1.7× 196 1.5× 56 1.3k
J. Joseph Melenhorst United States 18 275 0.6× 348 0.8× 249 0.8× 624 2.3× 163 1.2× 32 1.0k
Priscilla Yam United States 16 501 1.1× 179 0.4× 537 1.7× 241 0.9× 352 2.7× 26 1.3k
Hideki Ohminami Japan 15 207 0.4× 412 1.0× 283 0.9× 514 1.9× 90 0.7× 18 920
Ann E. Schmierer United States 5 211 0.5× 330 0.8× 293 0.9× 968 3.5× 141 1.1× 6 1.3k
Tsuyoshi Tange Japan 12 208 0.4× 256 0.6× 413 1.3× 367 1.3× 133 1.0× 26 1.2k
DT Scadden United States 10 337 0.7× 170 0.4× 137 0.4× 316 1.2× 55 0.4× 18 814
Manuel Schmidt Germany 14 214 0.5× 353 0.8× 273 0.9× 603 2.2× 40 0.3× 50 1.0k
MA Caligiuri United States 9 329 0.7× 229 0.5× 217 0.7× 671 2.5× 39 0.3× 10 1.1k

Countries citing papers authored by A Zander

Since Specialization
Citations

This map shows the geographic impact of A Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Zander more than expected).

Fields of papers citing papers by A Zander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Zander. The network helps show where A Zander may publish in the future.

Co-authorship network of co-authors of A Zander

This figure shows the co-authorship network connecting the top 25 collaborators of A Zander. A scholar is included among the top collaborators of A Zander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Zander. A Zander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zabelina, Tatjana, Francis Ayuk, Haefaa Alchalby, et al.. (2013). Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation. Bone Marrow Transplantation. 49(1). 126–130. 28 indexed citations
2.
Lioznov, Michael, Jean El Cheikh, York Hildebrandt, et al.. (2009). Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells. Bone Marrow Transplantation. 45(2). 349–353. 82 indexed citations
3.
Ocheni, Sunday, Tatjana Zabelina, Ingo Sobottka, et al.. (2008). EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplantation. 42(3). 181–186. 70 indexed citations
4.
Giordano, Frank A., Boris Fehse, Agnes Hotz‐Wagenblatt, et al.. (2006). Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions. Bone Marrow Transplantation. 38(3). 229–235. 6 indexed citations
5.
Oyekunle, Anthony, Nicolaus Kröger, Tatjana Zabelina, et al.. (2005). Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Bone Marrow Transplantation. 37(1). 45–50. 52 indexed citations
6.
Krüger, William, Anja Lange, Anita Badbaran, et al.. (2003). Detection of disseminated epithelial cancer cells by liquid culture—factors interfering with the standardization of assays. Cytotherapy. 5(3). 252–258.
7.
Finckenstein, Friedrich Graf, Tatjana Zabelina, Matthias Dürken, et al.. (2002). Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG. Klinische Pädiatrie. 214(4). 206–211. 1 indexed citations
8.
Hänel, Mathias, Nicolaus Kröger, Frank Kroschinsky, et al.. (2001). Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. Journal of Cancer Research and Clinical Oncology. 127(6). 387–395. 4 indexed citations
9.
Steffen, Martín, et al.. (2000). Serum Levels of Stem Cell Factor in Patients During Transplantation of Bone Marrow or Peripheral Blood Stem Cells. Journal of Hematotherapy & Stem Cell Research. 9(1). 55–61. 1 indexed citations
10.
Ayuk, Francis, Zhan Li, Klaus Kühlcke, et al.. (1999). Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements. Gene Therapy. 6(10). 1788–1792. 29 indexed citations
11.
Jung, R., Kay Uwe Petersen, William Krüger, et al.. (1999). Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. British Journal of Cancer. 81(5). 870–873. 134 indexed citations
12.
13.
Krüger, William, Ingo Sobottka, M Stockschläder, et al.. (1996). Fatal Outcome of Disseminated Candidosis after Allogeneic Bone Marrow Transplantation under Treatment with Liposomal and Conventional Amphotericin-B. A Report of 4 Cases with Determination of the Mic Values. Scandinavian Journal of Infectious Diseases. 28(3). 313–316. 3 indexed citations
14.
15.
Horstmann, Martin A., M Stockschläder, H. Kabisch, & A Zander. (1995). Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors [letter]. Blood. 85(5). 1404–1405. 4 indexed citations
16.
Hegewisch‐Becker, Susanna, Markus Fliegner, T Tsuruo, et al.. (1993). P-glycoprotein expression in normal and reactive bone marrows. British Journal of Cancer. 67(3). 430–435. 17 indexed citations
17.
Davis, Brian R., David H. Schwartz, Chris Johnson, et al.. (1991). Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. Journal of Virology. 65(4). 1985–1990. 119 indexed citations
18.
Dicke, K. A., et al.. (1990). Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia.. PubMed. 5(2). 111–8. 5 indexed citations
19.
Spitzer, Gary, A Zander, Miloslav Beran, et al.. (1980). Adherent cell-mediated inhibition of human leukemic myelopoiesis.. PubMed. 8(9). 1146–56. 3 indexed citations
20.
Spitzer, Gary, et al.. (1979). High dose chemotherapy with autologous bone marrow transfusion.. PubMed. 7 Suppl 5. 38–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.D. Donnenberg Breakdown of academic impact, for papers by Claude Baillou Breakdown of academic impact, for papers by J. Joseph Melenhorst Breakdown of academic impact, for papers by Priscilla Yam Breakdown of academic impact, for papers by Hideki Ohminami Breakdown of academic impact, for papers by Ann E. Schmierer Breakdown of academic impact, for papers by Tsuyoshi Tange Breakdown of academic impact, for papers by DT Scadden Breakdown of academic impact, for papers by Manuel Schmidt Breakdown of academic impact, for papers by MA Caligiuri
Rankless by CCL
2026